Home/Filings/4/0001209191-19-048930
4//SEC Filing

ANIDO VICENTE JR 4

Accession 0001209191-19-048930

CIK 0001337553other

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 5:43 PM ET

Size

7.2 KB

Accession

0001209191-19-048930

Insider Transaction Report

Form 4
Period: 2019-09-09
ANIDO VICENTE JR
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2019-09-09$18.93/sh+24,250$459,053195,631 total
  • Purchase

    Common Stock

    2019-09-09$19.95/sh+2,000$39,900197,631 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.86 to $19.05, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnotes to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.8128 to $19.9752, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnotes to this Form 4.

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1
  • filerCIK 0001207633

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 5:43 PM ET
Size
7.2 KB